Gain Therapeutics, Inc. (GANX)

Gain Therapeutics Statistics

Total Valuation

GANX has a market cap or net worth of $70.46 million. The enterprise value is $64.45 million.

Market Cap	70.46M
Enterprise Value	64.45M

Important Dates

The next estimated earnings date is Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

GANX has 35.95 million shares outstanding. The number of shares has increased by 74.59% in one year.

Current Share Class	35.95M
Shares Outstanding	35.95M
Shares Change (YoY)	+74.59%
Shares Change (QoQ)	+5.77%
Owned by Insiders (%)	3.72%
Owned by Institutions (%)	9.94%
Float	34.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	16.32
P/TBV Ratio	19.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.18.

Current Ratio	1.79
Quick Ratio	1.56
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -240.21% and return on invested capital (ROIC) is -127.16%.

Return on Equity (ROE)	-240.21%
Return on Assets (ROA)	-74.33%
Return on Invested Capital (ROIC)	-127.16%
Return on Capital Employed (ROCE)	-372.29%
Revenue Per Employee	n/a
Profits Per Employee	-$743,723
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, GANX has paid $757,446 in taxes.

Income Tax	757,446
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.66% in the last 52 weeks. The beta is 0.13, so GANX's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	-13.66%
50-Day Moving Average	1.85
200-Day Moving Average	1.89
Relative Strength Index (RSI)	53.22
Average Volume (20 Days)	727,389

Short Selling Information

The latest short interest is 1.27 million, so 3.53% of the outstanding shares have been sold short.

Short Interest	1.27M
Short Previous Month	422,327
Short % of Shares Out	3.53%
Short % of Float	3.67%
Short Ratio (days to cover)	1.46

Income Statement

Revenue	n/a
Gross Profit	-8.72M
Operating Income	-17.26M
Pretax Income	-17.84M
Net Income	-18.59M
EBITDA	-17.22M
EBIT	-17.26M
Earnings Per Share (EPS)	-$0.66

Balance Sheet

The company has $6.69 million in cash and $680,638 in debt, giving a net cash position of $6.01 million or $0.17 per share.

Cash & Cash Equivalents	6.69M
Total Debt	680,638
Net Cash	6.01M
Net Cash Per Share	$0.17
Equity (Book Value)	3.70M
Book Value Per Share	0.12
Working Capital	4.11M

Cash Flow

In the last 12 months, operating cash flow was -$18.45 million and capital expenditures -$946, giving a free cash flow of -$18.45 million.

Operating Cash Flow	-18.45M
Capital Expenditures	-946
Free Cash Flow	-18.45M
FCF Per Share	-$0.51

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GANX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-74.59%
Shareholder Yield	-74.59%
Earnings Yield	-26.39%
FCF Yield	-26.19%

Analyst Forecast

The average price target for GANX is $8.00, which is 308.16% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	308.16%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-16.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2